MRVL

Marvell Technology

$141.17

-0.02%
Nov 7, 2026
Bobby Quantitative Model
Marvell Technology is a fabless semiconductor designer whose core franchise is wired networking and connectivity silicon — custom ASICs, optical and copper transceivers, Ethernet switches, storage controllers, and data-center processors — sold into hyperscale data center, carrier, enterprise, and consumer end markets. It holds the second-highest market share in wired networking and has repositioned itself as a custom silicon partner of choice for hyperscalers building proprietary AI accelerators, making it a direct beneficiary of the shift away from merchant GPUs toward bespoke inference and training chips. The current investor debate is dominated by two opposing forces: a powerful AI-driven data-center growth story (data center now accounts for roughly $2.17 billion of quarterly revenue, with total revenue up 36.6% year over year) versus a highly controversial, steep-premium acquisition of Lumentum aimed at securing optical technology for AI infrastructure, which has raised dilution and integration concerns. That tension has produced extreme volatility — the stock is up roughly 44% over twelve months yet has collapsed more than 53% in the past month alone — leaving investors to weigh whether the selloff is a buying opportunity in a structural AI winner or a repricing of an increasingly expensive and acquisitive capital-allocation strategy.

People also watch

Nvidia

Nvidia

NVDA

Analysis
TSMC

TSMC

TSM

Analysis
Broadcom

Broadcom

AVGO

Analysis
Micron Technology

Micron Technology

MU

Analysis
AMD

AMD

AMD

Analysis

BobbyInvestment Opinion: Should I buy MRVL Today?

Rating: Hold with a speculative accumulation bias. The core thesis is that Marvell's operating engine — 36.55% year-over-year revenue growth to $2.739 billion, gross margin expanding roughly 480bp over two quarters to 53.14%, and $1.730 billion of trailing free cash flow — remains intact, while the 53.47% one-month collapse is a repricing of capital-allocation risk from the steep-premium Lumentum optics acquisition rather than a demand shock. The sell-side consensus of 39 Buys, 5 Holds and zero Sells with an average target of $313.73 (roughly +135% from $133.55) anchors the view that fundamentals have not broken, but with a beta of 2.327 and analyst targets that lag a -16.43% single-session drop, this is a position to size carefully rather than chase.

Supporting evidence is concrete: revenue rose from $2.418 billion in Q1 FY27 to $2.739 billion in Q2 (about 13% sequential), data center contributed $2.172 billion or roughly 79% of the total, operating income of $456.9 million equates to a 16.68% margin, and Q2 operating cash flow of $605.5 million comfortably covered $126.7 million of capex. The balance sheet is not the constraint — debt-to-equity of 0.335, a current ratio of 2.01 and $3.933 billion of cash — but valuation is: PS of 8.29x, EV/Sales of 14.97x and price-to-free-cash-flow near 351x leave no room for error, and the forward PE of 18.19x versus 25.46x trailing already capitalizes an earnings doubling. Even the lowest analyst target of $175 sits 31% above the current price, which argues the selloff has overshot, but the 2.5x spread between the $175 low and $450 high signals genuine disagreement about the Lumentum integration and the custom-ASIC ramp.

The rating would upgrade to Buy if the stock reclaims the $159.80 prior close and holds it while Lumentum dilution is quantified and optical revenue timelines are confirmed, or if the forward PE compresses toward the mid-teens on delivered EPS rather than hoped-for EPS. It would downgrade to Sell if a hyperscaler trims custom-ASIC orders in favor of merchant GPUs, if gross margin slips back below the 52.15% Q1 level, or if the stock breaks decisively below $133.55 and momentum liquidation drives it toward the $100-$110 zone. Net verdict: the stock has de-rated from its $329.88 peak to the lower quartile of its 52-week range and screens closer to fairly valued than overvalued on forward earnings, but the acquisition overhang and 2.33 beta mean it is a high-conviction, small-position holding rather than a clean value entry.

Sign up to view all

MRVL 12-Month Price Forecast

The forward view is genuinely two-sided: the operating trajectory — 36.55% revenue growth, 53.14% gross margin, $1.730 billion of trailing free cash flow — has not broken even as the stock has fallen 53.47% in a month, and the fact that even the lowest analyst target of $175 sits 31% above the current price argues the selloff has overshot. Against that, valuation still assumes near-flawless execution at a PS of 8.29x and price-to-free-cash-flow near 351x, and the Lumentum acquisition introduces dilution and integration risk precisely when Broadcom is compounding AI semiconductor revenue at 221%. The 2.33 beta and -57.79% max drawdown mean the path to the $313.73 consensus target is unlikely to be linear, which is why the base case carries 50% weight in a $175-$250 band rather than the headline upside. I would upgrade to bullish on confirmation that Lumentum dilution is contained and data-center growth holds above 30%, and downgrade to bearish if gross margin slips below the 52.15% Q1 level or a hyperscaler signals a shift back toward merchant GPUs.

Historical Price
Current Price $141.17
Average Target $212.50
High Target $450.00
Low Target $70.69

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Marvell Technology's 12-month outlook, with a consensus price target around $310.07 and implied upside of +119.6% versus the current price.

Average Target

$310.07

44 analysts

Implied Upside

+119.6%

vs. current price

Analyst Count

44

covering this stock

Price Range

$175 - $450

Analyst target range

Buy
39 (89%)
Hold
5 (11%)
Sell
0 (0%)

Coverage is deep and overwhelmingly bullish: 41 analysts cover MRVL with 39 Buy ratings, 5 Hold ratings, and zero Sells, producing a consensus recommendation of "strong_buy" and a recommendation mean of 1.386 (where 1.0 is a strong buy). The average target price of $313.73 implies roughly +135% upside from the current $133.55 — an extraordinary gap that reflects either a massive disconnect between analyst models and market pricing, or targets that have not yet been updated for the recent collapse. The consensus leans emphatically bullish, and the institutional ratings flow from October 7 shows broad reaffirmation (JP Morgan Overweight, Wolfe Outperform, Jefferies Buy, Wells Fargo Overweight, Evercore Outperform, Susquehanna Positive) with one notable upgrade (TD Cowen to Buy from Hold), suggesting the sell-side views the drawdown as an opportunity rather than a thesis break.

The target range is extremely wide — from a low of $175.00 to a high of $450.00 — a spread of more than 2.5x that signals very high uncertainty and divergent views on the AI custom-silicon opportunity. The high target of $450 likely assumes successful integration of the Lumentum optical acquisition, sustained 30%+ data-center growth, multiple expansion toward AI-leader peers, and new hyperscaler design wins; the low target of $175 (still 31% above the current price) likely prices in margin compression, dilution from the acquisition, and competitive share loss to Broadcom. Notably, even the most bearish analyst target sits above the current price, which is a powerful signal that the market selloff has overshot fundamental expectations — but with a beta of 2.33 and a 53% one-month decline, investors should recognize that analyst targets lag price action and the wide dispersion means position sizing and stop discipline matter more than the headline upside.

Drowning in data?

Find the real signal!

Bulls vs Bears: MRVL Investment Factors

The bull case rests on hard numbers: 36.55% revenue growth, 53.14% gross margin, $1.73 billion of TTM free cash flow, and a sell-side consensus of 39 Buys against zero Sells with an average target of $313.73. The bear case is equally concrete: a controversial premium-priced Lumentum acquisition, a 53.47% one-month collapse, a 2.33 beta, and a PS of 8.29x that still assumes near-flawless AI execution. On balance the fundamental evidence currently favors the bulls, because the operating trajectory (revenue up 13% sequentially, margins expanding) has not broken even as the stock has; the selloff looks like a repricing of capital-allocation risk rather than a demand shock. The single most important tension is whether the Lumentum deal converts into optical content wins inside AI clusters or instead becomes a dilutive integration drag — that one variable determines whether the $313.73 consensus target is reachable or the $175 low becomes the realistic anchor.

Bullish

  • Data-center revenue now 79% of total: The data center segment contributed $2.172 billion of the $2.739 billion in Q2 FY27 revenue, roughly 79% of the total, and total revenue grew 36.55% year over year. Sequential growth from $2.418 billion in Q1 to $2.739 billion implies about 13% quarter-over-quarter expansion, a slope rarely sustained at this revenue scale.
  • Gross margin expanding toward best-in-class: Gross margin rose to 53.14% in Q2 FY27 from 52.15% in Q1 and 48.37% in Q4 FY26, a roughly 480bp improvement over two quarters. Operating income of $456.9 million (16.68% margin) is the cleanest profitability gauge given large swings in other income and tax items.
  • Sell-side consensus is near-unanimous: 39 of 41 analysts rate MRVL Buy with zero Sells, a recommendation mean of 1.386 (strong buy). The average target of $313.73 implies about +135% upside from $133.55, and even the lowest target of $175 sits 31% above the current price.
  • Balance sheet and cash generation support the story: Debt-to-equity is a modest 0.335, the current ratio is 2.01, and cash stood at $3.933 billion at the end of Q2. Free cash flow TTM is $1.730 billion, with Q2 operating cash flow of $605.5 million comfortably covering $126.7 million of capex.

Bearish

  • Lumentum deal drives dilution and skepticism: The steep-premium acquisition of Lumentum to secure optical technology for AI infrastructure is the proximate cause of the recent collapse, with the stock down 53.47% in one month. The deal adds integration risk and dilution while the company already funded a $1.271 billion acquisition in Q1.
  • Valuation still prices in flawless execution: At a PS of 8.29x and EV/Sales of 14.97x, MRVL trades at a premium to the semiconductor industry, and price-to-free-cash-flow is roughly 351x. The forward PE of 18.19x versus 25.46x trailing requires earnings to roughly double, leaving little room for error.
  • Extreme volatility and technical breakdown: Beta is 2.327, max drawdown is -57.79%, and the stock sits at just 24.3% of its 52-week range after a -16.43% single-session drop on 65.8 million shares. It trails SPY by 47.55 percentage points over one month, signaling aggressive de-rating of the AI premium.
  • Customer concentration in hyperscale capex: With roughly 79% of revenue tied to data center and custom ASIC programs, the thesis depends on a handful of hyperscaler capex budgets. Any pause or reallocation toward merchant GPUs or in-house designs would hit the largest revenue pool directly.

MRVL Technical Analysis

MRVL is in a violent, high-volatility uptrend that has just suffered a severe drawdown: the stock is up 43.76% over the trailing year and 49.40% year-to-date, but the current price of $133.55 sits at just 24.3% of its 52-week range of $70.69 to $329.88. That positioning is the signature of a momentum name that has broken down from a parabolic advance rather than a stock quietly consolidating near highs — the 52-week high of $329.88 was set during the summer melt-up, and the stock has since surrendered roughly 60% from that peak, with a max drawdown of -57.79% confirming the severity of the reversal. For now the long-term trend structure remains technically intact (price is still well above the $70.69 low), but the stock is trading in the lower quartile of its range, which historically marks either a high-reward accumulation zone or an ongoing falling-knife phase depending on whether support holds.

Short-term momentum is unambiguously negative and decelerating sharply: the stock is down 53.47% over the past month and 38.94% over three months, a stark divergence from the +43.76% one-year gain and a clear signal that the intermediate trend has reversed even as the annual trend stays positive. The most alarming datapoint is the single-session move on the analysis date — a -16.43% decline from the prior close of $159.80 to $133.55 on volume of 65.8 million shares — which indicates capitulation-style selling rather than orderly profit-taking. Relative strength confirms the breakdown: MRVL trails SPY by 47.55 percentage points over one month and 33.73 points over three months, even though it still leads SPY by 35.58 points over twelve months, meaning the market is aggressively de-rating the stock's recent AI premium rather than abandoning the longer-term thesis outright.

Key technical levels are now well defined: immediate support sits at the $133.55 area (the current print and the low of the recent cascade), with the true floor at the 52-week low of $70.69 — a further ~47% below — while resistance is stacked at the $159.80 prior close, then the $196-$218 shelf from late October, and ultimately the $329.88 high. A decisive break below $133.55 would likely trigger momentum-fund liquidation toward the $100-$110 zone and put the 52-week low in play, whereas reclaiming $160 and then $196 would signal the panic selling was climactic and re-establish the uptrend. Risk management is paramount here: the beta of 2.327 means the stock is roughly 133% more volatile than the S&P 500, so position sizing should be materially smaller than a market-beta holding, and the 1.24 short ratio suggests short interest is not extreme, leaving room for further long-side unwinding before a squeeze dynamic could develop.

Beta

2.33

2.33x market volatility

Max Drawdown

-57.8%

Largest decline past year

52-Week Range

$71-$330

Price range past year

Annual Return

+55.3%

Cumulative gain past year

PeriodMRVL ReturnS&P 500
1m-48.6%-5.0%
3m-35.5%-4.9%
6m-17.4%-0.5%
1y+55.3%+9.6%
ytd+57.9%+7.8%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

MRVL Fundamental Analysis

The revenue trajectory is genuinely strong and accelerating: most recent quarterly revenue was $2.739 billion, up 36.55% year over year, and the sequential progression from $2.418 billion (Q1 FY27) to $2.739 billion (Q2 FY27) implies roughly 13% quarter-over-quarter growth — a pace rarely seen at this scale. The data center segment is the engine, contributing $2.172 billion, or approximately 79% of total quarterly revenue, which underscores both the opportunity and the concentration risk in hyperscale AI capex. The multi-quarter arc is compelling — revenue climbed from $1.895 billion in Q1 FY26 through $2.006 billion, $2.075 billion, $2.219 billion, and $2.418 billion to the latest $2.739 billion — but the investment case now hinges on whether custom AI silicon demand can sustain this slope against a backdrop of customer concentration and competitive pressure from Broadcom and merchant GPU alternatives.

Profitability has inflected decisively: Q2 FY27 net income was $308 million (a 11.24% net margin) with gross margin of 53.14%, up from a 52.15% gross margin in Q1 and a 48.37% gross margin in Q4 FY26, showing steady expansion. The prior-year comparison is stark — Q3 FY24 posted a net loss of $676.3 million on a 23.05% gross margin — so the company has executed a dramatic margin recovery, and the current 51.02% trailing gross margin and 16.33% operating margin are consistent with a fabless semiconductor model that is scaling toward best-in-class levels. The caveat is earnings quality: Q1 FY27 net income of just $34.5 million (1.43% net margin) versus $308 million in Q2 reflects large swings in other income/expense and tax items, and the trailing EPS of $0.039 looks distorted relative to the $0.34 quarterly EPS, so investors should focus on operating income ($456.9 million, 16.68% margin) as the cleaner profitability gauge.

Balance-sheet health is solid but cash generation is the swing factor: debt-to-equity is a modest 0.335, the current ratio is 2.01, and cash at the end of Q2 stood at $3.933 billion, giving ample liquidity. Free cash flow TTM is $1.730 billion, with quarterly FCF of $478.8 million in Q2 and $483.1 million in Q1, and operating cash flow of $605.5 million in the latest quarter comfortably covers $126.7 million of capex. However, the company is returning significant capital — $200 million of buybacks and $53.9 million of dividends in Q2 — while also funding a $1.271 billion acquisition in Q1, and the $326.2 million of stock-based compensation in Q2 is a meaningful non-cash drag that dilutes per-share economics; ROE of 18.66% and ROA of 4.13% are respectable but the low ROA reflects the asset-heavy balance sheet post-acquisition.

Quarterly Revenue

$2.7B

2026-08

Revenue YoY Growth

+36.5%

YoY Comparison

Gross Margin

53.1%

Latest Quarter

Free Cash Flow

$1.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Data Center

Open an Account, get $2 TSLA now!

Valuation Analysis: Is MRVL Overvalued?

Because net income is positive ($308 million in the latest quarter, with trailing EPS of $0.039 and a trailing PE of 25.46x), the PE ratio is the appropriate primary metric, though the trailing figure is distorted by prior-year losses and one-off items. The forward PE of 18.19x is the more meaningful anchor and implies the market expects earnings to roughly double from trailing levels — a reasonable expectation given the 36.6% revenue growth and margin expansion, but one that leaves little room for execution error. The gap between the 25.46x trailing and 18.19x forward multiple signals that consensus is pricing in substantial EPS growth, consistent with the analyst estimated EPS average of $28.95 (though this figure appears to be on a different basis than reported EPS and should be treated cautiously).

On peer comparison, MRVL screens expensive on sales-based metrics: the PS ratio of 8.29x and EV/Sales of 14.97x are elevated for a semiconductor company, and the EV/EBITDA of 15.44x is more moderate but still a premium to the broader semiconductor industry average (typically high-single to low-double digits). The PEG ratio of -0.063 is not meaningful given the earnings-base distortion, and the PCF ratio of 38.82x and price-to-free-cash-flow of roughly 351x (per historical ratios) highlight that cash-flow-based valuation is stretched. The premium is arguably justified by the 36.6% growth rate and 53% gross margins — a combination that few large-cap semis can match — but it also means the stock is priced for continued AI-driven acceleration, and any deceleration would compress multiples sharply.

Historically, MRVL's valuation has been extremely wide-ranging: the PS ratio has ranged from roughly 22.7x (Q3 FY23) to 61.4x (Q2 FY27 per historical ratios), and the PE ratio has swung from negative territory during loss-making periods to over 1,000x in low-earnings quarters. The current PS of 8.29x on the live valuation data appears to reflect the post-selloff price of $133.55 and is well below the 61.4x historical print, suggesting the stock has de-rated substantially from its peak — but the historical ratios are computed on different price points and earnings bases, so the comparison is imperfect. Net-net, the current multiple sits in the lower half of its own historical band, which supports a value-opportunity interpretation, but the extreme volatility of the historical range means the market has repeatedly repriced this name by 50%+ in both directions.

PE

25.5x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 11x~1055x

vs. Industry Avg

54.4x

Industry PE ~54.4x*

EV/EBITDA

15.4x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on the cost of the acquisition strategy and the quality of reported earnings. The company funded a $1.271 billion acquisition in Q1 while simultaneously returning $200 million of buybacks and $53.9 million of dividends in Q2, and the pending Lumentum deal at a steep premium raises the prospect of further dilution on top of $326.2 million of quarterly stock-based compensation. Earnings volatility is real: net income swung from $34.5 million in Q1 FY27 (1.43% margin) to $308 million in Q2 on a -$266.8 million other-income swing, and trailing EPS of $0.039 versus $0.34 quarterly EPS shows how distorted the reported base is. Revenue concentration compounds this — data center is roughly 79% of the $2.739 billion quarterly total, so a single hyperscaler capex pause would hit the majority of the business, and the forward PE of 18.19x versus 25.46x trailing means the market is already capitalizing an earnings doubling that must be delivered. Market and competitive risks are dominated by valuation compression and the Broadcom problem. At a PS of 8.29x and EV/Sales of 14.97x, MRVL carries a premium to the semiconductor industry, and with price-to-free-cash-flow near 351x, any deceleration in the 36.55% growth rate would compress multiples violently — the beta of 2.327 means the stock moves roughly 133% more than the S&P 500, so sector rotation away from AI semis is amplified. Broadcom's AI semiconductor revenue surging 221% to $16.7 billion underscores that the custom-silicon prize is contested by a far larger, better-capitalized rival, and the Lumentum optics deal is itself a response to competitive pressure rather than a position of strength. The worst-case scenario is a chain in which Lumentum integration costs run over budget, dilution lands before optical revenue ramps, and a hyperscaler trims custom-ASIC orders in favor of merchant GPUs — a combination that would force analysts to cut targets toward the $175 low. From $133.55, a move to the 52-week low of $70.69 would be a loss of roughly 47%, and the -57.79% max drawdown shows that magnitude of decline has already happened once; a break below the $133.55 support would likely trigger momentum-fund liquidation into the $100-$110 zone first.

FAQ

Ranked by severity: first, customer and end-market concentration — data center is roughly 79% of the $2.739 billion quarterly revenue, so a single hyperscaler capex pause or a shift toward merchant GPUs would hit the majority of the business directly. Second, capital-allocation and dilution risk from the steep-premium Lumentum acquisition, layered on top of $326.2 million of quarterly stock-based compensation and a $1.271 billion acquisition already funded in Q1. Third, valuation compression — at a PS of 8.29x and price-to-free-cash-flow near 351x, with a beta of 2.327, any growth deceleration is amplified into a violent multiple reset, as the -57.79% max drawdown already demonstrated. Fourth, competitive pressure from Broadcom, whose AI semiconductor revenue surged 221% to $16.7 billion, contesting the custom-silicon prize with far greater scale. Earnings quality is a secondary concern, given the swing from $34.5 million of Q1 net income to $308 million in Q2 on a -$266.8 million other-income item.

The 12-month view is split into three scenarios. The base case carries 50% probability and a $175-$250 range, assuming growth moderates toward the high-teens to low-20s, gross margin holds in the low-50s, and Lumentum dilution is absorbed without a second raise. The bull case carries 25% probability and a $313.73-$450 range, requiring contained dilution, a confirmed optical ramp, 30%+ data-center growth with margins above 53%, and new hyperscaler design wins. The bear case carries 25% probability and a $70.69-$133.55 range, driven by a hyperscaler pivot to merchant GPUs, Lumentum integration overruns, and Broadcom share gains. The base case is most likely, and its key assumption is that the 53.14% gross margin holds while the market waits for optical revenue to materialize; the $313.73 consensus average is achievable only if the bull-case conditions are met.

The answer depends on which multiple you weight. On sales, MRVL is expensive: a PS of 8.29x, EV/Sales of 14.97x and EV/EBITDA of 15.44x are premiums to the typical semiconductor range, and price-to-free-cash-flow near 351x (with a PCF of 38.82x) is stretched. On forward earnings it looks far more reasonable: the forward PE of 18.19x versus 25.46x trailing implies the market expects EPS to roughly double, which is plausible against 36.55% revenue growth and 480bp of gross-margin expansion over two quarters. The stock has also de-rated hard — it sits at just 24.3% of its 52-week range after falling from a $329.88 peak — so the current multiple is in the lower half of its own historical band. Net, the market is paying a premium for growth but no longer an extreme one; the valuation implies continued AI-driven acceleration, and any deceleration would compress multiples quickly.

On risk/reward, the setup is asymmetric but not clean. The average analyst target of $313.73 implies roughly +135% upside from $133.55, and even the lowest target of $175 sits about 31% above the current price, while the realistic downside to the 52-week low of $70.69 is roughly -47%. That is a favorable ratio on paper, but it comes with a 2.327 beta, a -57.79% max drawdown, and a PS of 8.29x that assumes near-flawless AI execution. The operating engine has not broken — 36.55% revenue growth, 53.14% gross margin, $1.73 billion of TTM free cash flow — so the selloff looks like a repricing of Lumentum capital-allocation risk rather than a demand shock. It is a reasonable buy only for investors with a multi-year horizon, tolerance for another 40%+ drawdown, and a willingness to size the position small; it is not a good buy for anyone who needs near-term stability or cannot stomach the volatility.

This is a long-term holding, not a trading vehicle for most investors. The growth stage is mid-to-late — $2.739 billion in quarterly revenue growing 36.55% — with earnings visibility that depends on a handful of hyperscaler programs, and the beta of 2.327 means short-term price action is dominated by sentiment rather than fundamentals, as the -16.43% single-session drop on 65.8 million shares shows. The dividend is negligible (0.30% yield, 7.68% payout), so there is no income cushion to support a short horizon. A concrete minimum holding period is 18-24 months, long enough for the Lumentum integration to be quantified and for optical and custom-ASIC revenue to show up in reported numbers. Short-term traders could trade the $133.55 support and $159.80 resistance levels, but that is a momentum exercise, not an investment in the AI custom-silicon thesis.